Silberstein Charles 4
4 · Applied Therapeutics Inc. · Filed Dec 14, 2020
Insider Transaction Report
Form 4
Silberstein Charles
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-12-10+92,850→ 92,850 totalExercise: $23.15Exp: 2030-12-10→ Common Stock (92,850 underlying)
Footnotes (1)
- [F1]One-fourth (1/4th) of the shares subject to the Option shall vest on December 10, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.